Biomarkers for Psychiatric Disorders
Biological markers, as physiological indicators of disease, hold immense promise for diagnostics and clinical drug trials. While for other complex disorders like diabetes and heart disease a limited number of markers are at hand, there are currently no biomarkers available for psychiatric disorders....
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Boston, MA :
Springer US,
2009.
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Blood and Brain Gene Expression in Major Psychiatric Disorders: A Search for Biomarkers
- Biomarkers in Schizophrenia
- Proteomic Strategies for Biomarker Discovery: From Differential Expression to Isoforms to Pathways
- Schizophrenia Biomarkers: A Means to Advance Disease Understanding, Diagnosis and Treatment
- RNA Biomarkers in Schizophrenia
- Metabolomics: A Global Biochemical Approach to the Discovery of Biomarkers for Psychiatric Disorders
- Animal Models for Schizophrenia: A Brief Overview
- Synaptoproteomics of Existing and new Animal Models of Depression
- Animal Models for Anxiety Disorders
- Animal Models of Affective Behaviors and Drug Addiction
- Neuroimaging Biomarkers in Schizophrenia
- Sleep EEG Provides Biomarkers in Depression
- Strategies to Identify Biomarkers for Depression
- Pharmacogenetics of Antidepressant Response
- Perspectives for an Integrated Biomarker Approach to Drug Discovery and Development
- Hunting for Peripheral Biomarkers to Support Drug Development in Psychiatry
- Biomarkers for the Development of Antidepressant and Anxiolytic Drugs
- DNA Biomarkers for Pharmacogenomics and Personalized Medicine
- Biological Modeling in the Discovery and Validation of Cognitive Dysfunctions Biomarkers.
